Kimia Biosciences Limited at its board meeting held on May 30, 2022 appointed Mr. Sameer Goel as Chief Executive Officer of the Company. Mr. Sameer Goel holds a tall stature in the Indian API market with more than 23 years of experience and has strong multi-dimensional capabilities in the areas of Business Development, Product Development, Strategic Marketing and Operations Management.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
52 INR | -0.91% |
|
-6.08% | +41.58% |
1st Jan change | Capi. | |
---|---|---|
+41.58% | 29.68M | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- KIMIABL Stock
- News Kimia Biosciences Limited
- Kimia Biosciences Limited Appoints Sameer Goel as Chief Executive Officer